The Lyme disease (Borrelia) VlsE1-IgG and pepC10-IgM antibodies test is a diagnostic tool used to identify the presence of antibodies in the body that are specifically related to Lyme disease caused by the Borrelia burgdorferi bacteria. This test helps healthcare professionals confirm an active or recent infection by measuring the levels of IgG and IgM antibodies against two specific proteins produced by the bacteria. By detecting these antibodies, the test aids in accurate and early detection of Lyme disease, allowing for prompt treatment and management.
To continue booking, you need to select at least 1 test
* Results are available same day by 9 p.m. 99% of the time. On rare occasions, it may take up to 3 business days to receive results.
Lyme disease antibody titer tests assess antibodies that are specifically targeted at the bacteria responsible for this condition. These antibodies play a crucial role in the body's immune response. The tests focus on two primary types of antibodies: immunoglobulin M (IgM) and immunoglobulin G (IgG).
Testing is typically recommended when an individual exhibits symptoms of Lyme disease and has a confirmed or potential history of exposure to ticks known to carry the Borrelia bacteria. Nonetheless, it's important to bear in mind that antibodies require time to develop, so the timing of the test is a crucial factor to consider.
A blood sample can be collected in a doctor's office or another medical facility. If a cerebrospinal fluid test is required, it can be performed as an outpatient procedure known as a lumbar puncture, typically conducted in a hospital setting. Following collection, these samples are sent to an accredited laboratory for analysis.
Lyme disease is a condition resulting from an infection caused by a bacterium transmitted through the bite of specific types of ticks. Symptoms can manifest initially at the site of the tick bite or appear elsewhere on the skin, and in some cases, they can progress to affect various other parts of the body. Lyme disease is brought about by a group of bacteria collectively known as Borrelia.
The primary goal of the most common Lyme disease testing is to ascertain whether you have produced antibodies as a result of prior exposure to the Borrelia bacteria responsible for causing Lyme disease. Antibodies are proteins generated by the immune system with the specific function of targeting and combating threats such as bacteria and viruses.
IgM antibodies typically reach their highest levels within a few weeks following infection with Borrelia bacteria and start to decline approximately 4-6 months afterward. On the other hand, IgG antibodies take longer to develop, becoming detectable about 4-6 weeks after exposure and possibly peaking 4-6 months after exposure. While IgM is often linked to an ongoing infection, both IgM and IgG can remain in the bloodstream for many years.
Conducting tests for IgM and IgG antibodies can provide evidence of exposure to Borrelia bacteria, but it alone cannot definitively confirm whether or not you have Lyme disease.
Lyme disease testing is typically prescribed by a healthcare provider when there are indications or symptoms aligning with Lyme disease.
A blood sample can be collected in a healthcare provider's office or another clinical setting. If a cerebrospinal fluid test is deemed necessary, it can be conducted through an outpatient procedure known as a lumbar puncture, typically performed at a hospital. Subsequently, these samples are examined in an accredited laboratory for analysis.
There are available options for conducting at-home testing for antibodies associated with Lyme disease. Typically, these test kits involve collecting a blood sample by pricking your fingertip. This blood sample is subsequently sent to a laboratory for analysis, specifically to detect IgM and IgG antibodies.
Best Prices
Our fully automated private laboratory with cutting edge technology is able to reduce costs while increasing consistency and reproducibility of results.
Faster Service
We have designed our clinics and testing processes to be efficient, reducing wait times and time for results.
More Precise Information
Our test reports provide more precise information on test results, making it easier to monitor any changes in your health over time.
Free Parking
All our clinics provide free and available parking, helping you to save even more money and time.
Customer Support
Our online booking portal and helpful testing center staff help to make diagnostic testing more convenient and compassionate.
IMPLEMENT AFFORDABLE ACTION
Companies and institutions can deploy large-scale diagnostic testing at a fraction of the cost of testing centers with Lilium’s automated laboratory testing platforms and reporting.
STAY AHEAD OF OUTBREAKS
Lilium's pioneering testing system secures workplaces and communities against expensive shutdowns by keeping businesses and organizations ahead of outbreaks.
REDUCE RISKS
Robotic analysis improves accuracy of results by drastically reducing the risk of false negatives and positives.
To make an appointment, please choose from one of our clinics below:
Monday - Saturday
7:00 - 10:00
12:00 - 15:00
We provide FREE parking at our convenient locations
Our downtown Montreal location is located on the mezzanine level of the Alexis Nihon Center with 1 hour free indoor parking. Atwater metro station has a direct inside connection to Alexis Nihon.
If you’re driving to our Laval location, we are right off Autoroute 15 and have plenty of free parking.
If you arrive by public metro, there is a walkway to our lab from Metro Montmorency (a 20 minute walk).
What our customers say about us
ASK US ANYTHING
We're here to help make sense of it all.
Or send us an e-mail